Skip to main content

Table 1 Anthropometrics, hemodynamics, medication use, and fasted state in patients with or without coronary microvascular dysfunction (CMD)

From: Standard exercise stress testing attenuates peripheral microvascular function in patients with suspected coronary microvascular dysfunction

  No CMD CMD
All Patients Non-EX Exercisers All Patients Non-EX Exercisers
n 34 21 13 42 25 17
Sex, male, n (%) 13 (38) 7 (33) 6 (46) 13 (31) 8 (32) 5 (29)
Age (years) 55 ± 13 58 ± 13 51 ± 13 60 ± 13 62 ± 13 57 ± 11
Body mass (kg) 81.8 ± 19.0 76.8 ± 18.4 90.0 ± 17.6 78.1 ± 15.4 79.1 ± 14.6 76.7 ± 16.8
Height (m) 1.69 ± 0.10 1.67 ± 0.10 1.73 ± 0.08 1.66 ± 0.10 1.66 ± 0.08 1.67 ± 0.12
BMI (kg/m2) 29 ± 6 27 ± 6 30 ± 6 28 ± 4 29 ± 4 27 ± 5
Resting SBP (mmHg) 124 ± 15 124 ± 18 124 ± 10 123 ± 12 126 ± 12 117 ± 11
Resting DBP (mmHg) 75 ± 8 76 ± 8 74 ± 8 76 ± 9 77 ± 9 74 ± 9
Resting HR (bpm) 67 ± 12 62 ± 9 74 ± 13a 68 ± 13 65 ± 13 72 ± 12a
Medication use, n (%)
 Anti-Hypertensive 21 (62) 13 (62) 8 (62) 35 (83)† 21 (84) 14 (82)
 Anti-Cholesterol 19 (56) 12 (57) 7 (54) 26 (62) 16 (64) 10 (59)
Fasted, n (%) 4 (12) 3 (14) 1 (8) 11 (26) 8 (32) 3 (18)
  1. Non-EX Non-Exercisers, CMD Coronary Microvascular Dysfunction, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HR Heart Rate, BMI Body Mass Index. a indicates a significant exercise effect. † indicates a significant effect of CMD. Mean ± SD